Reuters reported  KKR has lined up a syndicate of lenders led by Credit Suisse that includes Bank of America Merrill Lynch, Morgan Stanley, RBC Capital Markets, HSBC and Mizuhoto to support its leveraged buyout of vitamin company Nature’s Bounty.

Reuters said that KKR, a private equity firm, aims to take a majority stake in the vitamin and nutritional supplement producer away from The Carlyle Group.